RadNet Announces Expiration of Its Tender Offer and Consent Solicitation for its 10 3/8% Senior Notes due 2018

RadNet Announces Expiration of Its Tender Offer and Consent

Solicitation for its 10 3/8% Senior Notes due 2018

LOS ANGELES, April 4, 2014 (GLOBE NEWSWIRE)

-- RadNet, Inc. (Nasdaq: RDNT) (the "Company"), a national leader in providing high-quality, cost-effective, fixed-site

outpatient diagnostic imaging services through a network of 250 owned and/or operated outpatient imaging centers, today announced

the expiration and final results of its previously announced cash tender offer for any and all of its outstanding $200,0000,000

aggregate principal amount of 10 3/8% Senior Notes due 2018 (the "Notes") and the related solicitation of consents

to amend the indenture governing the Notes (the "Consent Solicitation"). The tender offer expired pursuant to its terms

at 11:59 P.M., New York City time, on April 3, 2014 (the "Expiration Date").

On March 25, 2014 (the "Initial Payment

Date"), the Company made a payment in cash for all Notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014

(the "Consent Payment Deadline"). As of the Consent Payment Deadline, the Company had received tenders and consents

in respect of $193,464,000 aggregate principal amount of the Notes, representing 96.73% of the outstanding Notes, all of which

were accepted for purchase. The total consideration for each $1,000 principal amount of Notes validly tendered and not withdrawn

at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the "Total Consideration"), which

amount included a consent payment (the "Consent Payment") of $30.00 per $1,000 principal amount of Notes. In addition,

all Notes accepted for payment received accrued and unpaid interest in respect of such Notes from the last interest payment date

prior to the applicable settlement date to, but not including, the applicable settlement date.

Between the Consent Payment Deadline and

the Expiration Date, the Company received no additional tenders of Notes.

As of the Consent Payment Deadline, the

Company also received the required consents to amend the indenture governing its Notes. On March 21, 2014, the Company, the

guarantors party thereto, and U.S. Bank National Association, as trustee, entered into a supplemental indenture which eliminated

or modified certain restrictive covenants (not including the covenant to pay interest and premium, if any, on and principal of,

the Notes when due), and eliminated or modified certain events of default and certain other provisions contained in the indenture

governing the Notes (the "Supplemental Indenture"). The Supplemental Indenture became operative on the Initial

A total of approximately $6,536,000 in

aggregate principal amount of the Notes remained outstanding at the Expiration Date. As previously announced, the Company has called

for redemption all of its remaining outstanding Notes not purchased prior to the Expiration Date, with a redemption date of April

24, 2014 (the "Redemption Date"). Upon redemption, the holders of the Notes being redeemed will receive a redemption

price equal to 105.188% of the outstanding principal amount of the Notes being redeemed (or $1,051.88 per $1,000 in principal amount

of the Notes) plus accrued and unpaid interest, if any, up to, but excluding the Redemption Date.

This press release does not constitute

a notice of redemption under the optional redemption provisions of the indenture governing the Notes, nor does it constitute an

offer to sell, or a solicitation of an offer to buy, any security. The tender offer and consent solicitation is made only by means

of the Offer to Purchase and the related letter of transmittal. No offer, solicitation, or sale will be made in any jurisdiction

in which such an offer, solicitation, or sale would be unlawful.

RadNet, Inc. is the leading national provider

of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging

revenue. RadNet has a network of 250 owned and/or operated outpatient imaging centers. RadNet's core markets include California,

Maryland, Delaware, New Jersey, New York and Rhode Island. Together with affiliated radiologists, and inclusive of full-time and

per diem employees and technicians, RadNet has a total of approximately 6,300 employees. For more information, visit http://www.radnet.com.

"Safe Harbor" Statement

Under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking

statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange

Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements related to the redemption

of the Notes. These forward-looking statements involve known and unknown risks, uncertainties and other factors discussed in RadNet,

Inc.'s filings with the Securities and Exchange Commission (the "SEC"). Any forward-looking statements speak only as

of the date of this press release and, except to the extent required by applicable securities laws, RadNet, Inc. expressly disclaims

any obligation to update or revise any of them to reflect actual results, any changes in expectations or any change in events.

If RadNet, Inc. does update one or more forward-looking statements, no inference should be drawn that it will make additional updates

with respect to those or other forward-looking statements. For additional information concerning risks, uncertainties and other

factors that may cause actual results to differ from those anticipated in the forward-looking statements, and risks to RadNet,

Inc.'s business in general, please refer to its SEC filings, including its Annual Report on Form 10-K for the fiscal year ended

December 31, 2013, as amended.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer